Search research articles
Contact Us
Filters
Showing results (21-30 of 24) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 24 results.
Journal of Medicinal Chemistry
|
February 2, 2022
Discovery of Non-Nucleotide Small-Molecule STING Agonists <i>via</i> Chemotype Hybridization
Emily C Cherney, Liping Zhang, Julian Lo, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 30, 2006
Synthesis and SAR of pyrrolotriazine-4-one based Eg5 inhibitors
Kyoung Soon Kim, Songfeng Lu, Lyndon A Cornelius, et al.
Journal of Medicinal Chemistry
|
March 6, 2009
Discovery of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a selective and orally efficacious inhibitor of the Met kinase superfamily
Gretchen M Schroeder, Yongmi An, Zhen-Wei Cai, et al.
ACS Medicinal Chemistry Letters
|
August 20, 2015
Discovery of a Highly Selective JAK2 Inhibitor, BMS-911543, for the Treatment of Myeloproliferative Neoplasms
Honghe Wan, Gretchen M Schroeder, Amy C Hart, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 24) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 24 results.
Journal of Medicinal Chemistry
|
February 2, 2022
Discovery of Non-Nucleotide Small-Molecule STING Agonists <i>via</i> Chemotype Hybridization
Emily C Cherney, Liping Zhang, Julian Lo, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 30, 2006
Synthesis and SAR of pyrrolotriazine-4-one based Eg5 inhibitors
Kyoung Soon Kim, Songfeng Lu, Lyndon A Cornelius, et al.
Journal of Medicinal Chemistry
|
March 6, 2009
Discovery of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a selective and orally efficacious inhibitor of the Met kinase superfamily
Gretchen M Schroeder, Yongmi An, Zhen-Wei Cai, et al.
ACS Medicinal Chemistry Letters
|
August 20, 2015
Discovery of a Highly Selective JAK2 Inhibitor, BMS-911543, for the Treatment of Myeloproliferative Neoplasms
Honghe Wan, Gretchen M Schroeder, Amy C Hart, et al.
Page
of 3